Helen Goodridge, PhD, is an immunologist whose research focuses on neutrophils, macrophages and dendritic cells, which are key players in innate immunity and inflammation. The Goodridge lab is characterizing the mechanisms that regulate the production of these cells (myelopoiesis), the signals that instruct their responses to microbial components and other "danger signals," and the roles of these cells in antimicrobial immunity, inflammatory disease, neurodegenerative disease, cancer and aging.

• Undergraduate: University of Cambridge, 1997
• Doctorate: University of Glasgow, 2001

• Cancer Institute (Samuel Oschin Comprehensive Cancer Institute)
• Biomedical Sciences
• Cancer
• Medicine
• Regenerative Medicine Institute (Board of Governors Regenerative Medicine Institute)

• Director, American Association of Immunologists' Introductory Course in Immunology, 2019 -
• Dr. David L. Rimoin Teaching Excellence Award, Cedars-Sinai Graduate Program in Biomedical Science and Translational Medicine, 2016
• Cedars-Sinai Postdoctoral Scientist Program Recognition Award, 2015
• UCLA Clinical and Translational Science Institute Recognition Award, 2012
• Promega Young Immunologist of the Year, 2002

Click here for a list of peer-reviewed publications.

• Yáñez A, Coetzee SG, Olsson A, Muench DE, Berman BP, Hazelett DJ, Salomonis N, Grimes HL, Goodridge HS. Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes. Immunity. 2017;47(5):890-902
• Hassanzadeh-Kiabi N, Yáñez A, Dang I, Martins GA, Underhill DM, Goodridge HS. Autocrine Type I IFN Signaling in Dendritic Cells Stimulated with Fungal β-Glucans or Lipopolysaccharide Promotes CD8 T Cell Activation. J Immunol. 2017;198(1):375-382.
• Yáñez A, Ng MY, Hassanzadeh-Kiabi N, Goodridge HS. IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil versus monocyte production. Blood. 2015;125(9):1452-1459.